CIK 0001627223
- Large accelerated filer
Chemours Co
Sign in to watch- Ticker
- CC
- Exchange
- NYSE
- Industry
- Chemicals & Allied Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464845564
- Phone
- +1 302-773-1000
- Business address
- 1007 MARKET STREET, WILMINGTON, DE, 19801
- Former names
- Chemours Company, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-01 | Abbott Matthew S SVP, Chief Ent. Transf. Ofc. | Shares withheld for taxes | −453 | $23.31 | $11K | 45,837.18 |
| 2024-05-08 | Abbott Matthew S Interim CFO | Grant or award | +11,818 | 46,106.22 | ||
| 2024-05-08 | Abbott Matthew S Interim CFO | Grant or award · Stock Option (Right to Buy) | +31,614 | 31,614 | ||
| 2024-05-08 | Abbott Matthew S Interim CFO | Grant or award · Performance Stock Option (Right to Buy) | +32,879 | 32,879 | ||
| 2024-03-27 | Abbott Matthew S Interim CFO | Grant or award | +6,331 | 36,327.22 | ||
| 2024-03-27 | Abbott Matthew S Interim CFO | Shares withheld for taxes | −2,039 | $28.88 | $59K | 34,288.22 |
| 2024-03-01 | Abbott Matthew S Interim CFO | Shares withheld for taxes | −4,415 | $20.78 | $92K | 29,931.4 |
| 2023-08-01 | Abbott Matthew S SVP, Chief Enterprise Transfor | Grant or award | +4,069 | 34,044.3 | ||
| 2023-06-08 | Abbott Matthew S SVP, Chief Enterprise Transfor | Exercise or conversion | +8,912 | $14.43 | $129K | 38,781.12 |
| 2023-06-08 | Abbott Matthew S SVP, Chief Enterprise Transfor | Sale | −8,912 | $34.20 | $305K | 29,869.12 |
| 2023-06-08 | Abbott Matthew S SVP, Chief Enterprise Transfor | Exercise or conversion · Stock Option (Right to Buy) | −8,912 | 0 | ||
| 2021-05-27 | Abbott Matthew S VP, CAO & Controller | Exercise or conversion | +8,913 | $14.43 | $129K | 42,874.65 |
| 2021-05-27 | Abbott Matthew S VP, CAO & Controller | Sale | −8,913 | $35.61 | $317K | 33,961.65 |
| 2021-05-27 | Abbott Matthew S VP, CAO & Controller | Exercise or conversion · Stock Option (Right to Buy) | −8,913 | 17,824 | ||
| 2021-03-01 | Abbott Matthew S VP, CAO & Controller | Shares withheld for taxes | −581 | $24.01 | $14K | 22,117.07 |
| 2021-03-01 | Abbott Matthew S VP, CAO & Controller | Grant or award | +1,249 | 23,366.07 | ||
| 2021-03-01 | Abbott Matthew S VP, CAO & Controller | Grant or award | +10,412 | 33,778.07 | ||
| 2021-03-01 | Abbott Matthew S VP, CAO & Controller | Grant or award · Stock Option (Right to Buy) | +12,269 | 12,269 | ||
| 2020-03-02 | Abbott Matthew S VP, CAO & Controller | Grant or award | +17,325 | 21,843 | ||
| 2020-03-02 | Abbott Matthew S VP, CAO & Controller | Grant or award · Stock Option (Right to Buy) | +26,737 | 26,737 |
Page 1 of 2 · 21 trades